240 related articles for article (PubMed ID: 28476226)
41. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
42. [Genetics of familial pituitary adenomas].
Beckers A; Jaffrain-Rea ML; Daly AE
Bull Acad Natl Med; 2009 Oct; 193(7):1557-70; discussion 1570-1. PubMed ID: 20669636
[TBL] [Abstract][Full Text] [Related]
43. [Familial pituitary adenomas: clinical and genetic aspects].
Bricaire L; Brue T
Ann Endocrinol (Paris); 2007 Jun; 68 Suppl 1():9-11. PubMed ID: 17961654
[TBL] [Abstract][Full Text] [Related]
44. [Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas].
Vacchiano V; Seleme S; Daly AF; Beckers A; Valdés-Socin H
Medicina (B Aires); 2020; 80(2):181-184. PubMed ID: 32282328
[TBL] [Abstract][Full Text] [Related]
45. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
[TBL] [Abstract][Full Text] [Related]
46. Screening for genetic causes of growth hormone hypersecretion.
Rostomyan L; Beckers A
Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
[TBL] [Abstract][Full Text] [Related]
47. The pathophysiology of pituitary adenomas.
Dworakowska D; Grossman AB
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):525-41. PubMed ID: 19945021
[TBL] [Abstract][Full Text] [Related]
48. Genetic and Epigenetic Causes of Pituitary Adenomas.
Chang M; Yang C; Bao X; Wang R
Front Endocrinol (Lausanne); 2020; 11():596554. PubMed ID: 33574795
[TBL] [Abstract][Full Text] [Related]
49. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
50. Analysis of the MEN1 gene in sporadic pituitary adenomas.
Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
[TBL] [Abstract][Full Text] [Related]
51. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A; Aaltonen LA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
[TBL] [Abstract][Full Text] [Related]
52. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
53. Overview of genetic testing in patients with pituitary adenomas.
Beckers A; Rostomyan L; Daly AF
Ann Endocrinol (Paris); 2012 Apr; 73(2):62-4. PubMed ID: 22503805
[TBL] [Abstract][Full Text] [Related]
54. The Genetics of Pituitary Adenomas.
Tatsi C; Stratakis CA
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31877737
[TBL] [Abstract][Full Text] [Related]
55. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
56. Familial pituitary adenomas - who should be tested for AIP mutations?
Korbonits M; Storr H; Kumar AV
Clin Endocrinol (Oxf); 2012 Sep; 77(3):351-6. PubMed ID: 22612670
[TBL] [Abstract][Full Text] [Related]
57. Genomic Alterations in Sporadic Pituitary Tumors.
Bi WL; Larsen AG; Dunn IF
Curr Neurol Neurosci Rep; 2018 Feb; 18(1):4. PubMed ID: 29396598
[TBL] [Abstract][Full Text] [Related]
58. Familial pituitary adenomas.
Tichomirowa MA; Daly AF; Beckers A
J Intern Med; 2009 Jul; 266(1):5-18. PubMed ID: 19522822
[TBL] [Abstract][Full Text] [Related]
59. HEREDITARY PITUITARY TUMOR SYNDROMES: GENETIC AND CLINICAL ASPECTS.
García-Guzmán B; Portocarrero-Ortiz L; Dorantes-Argandar AA; Mercado M
Rev Invest Clin; 2020; 72(1):8-18. PubMed ID: 32132734
[TBL] [Abstract][Full Text] [Related]
60. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
